Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,579.10
(
0.20%
)
US TECH 100
29,500.00
(
0.26%
)
Dow Jones
50,987.59
(
0.63%
)
Brent Oil
90.37
(
-1.96%
)
Bitcoin
73,459.05
(
-0.11%
)
News Focus
News Focus
Post# of 648882
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Tuff-Stuff

Send PM Follow Ignore
Followers 217
Posts 247348
Boards Moderated 2
Alias Born 04/06/2006

Tuff-Stuff

Re: Tuff-Stuff post# 509068

Friday, 05/10/2013 7:53:10 AM

Friday, May 10, 2013 7:53:10 AM

Post# of 648882
Pfizer (PFE) updates Durect (DRRX) on Remoxy, saying that it's "considering its options", and that if it elects to continue development of Remoxy, "we would not expect to submit a response to the "complete response" letter before mid-2015." (PR) This is less positive than expected by SA author Jason Napodano; shares are -12.6% premarket.

Concentrate, and ASK the 8-Ball!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today